Meeting Banner
Abstract #5551

An Approach for Accurate Quantification of Hepatic Metastatic Burden during MRI-Guided Laser Ablation: Impact on Management Decisions in 41 Patients

Danial I Mir1, Kareem K Elfatairy1,2, Debra Overby Weber1, and Sherif G Nour1,3

1Radiology and Imaging Sciences, Emory University Hospital, Atlanta, GA, United States, 2Interventional MRI Program, Emory University Hospital, Atlanta, GA, United States, 3School of Medicine, Emory University, Atlanta, GA, United States

Treatment of patients with metastatic liver disease requires accurate quantification of hepatic tumor burden and precise three dimensional localization. We demonstrate that intraprocedural MRI utilizing IV gadoxetate disodium (EovistĀ®) administration with controlled breath suspension under general anesthesia results in the detection additional hepatic metastatic deposits in 25% of cases, not appreciated on prior diagnostic imaging. In 88% of these cases this discovery led to a change in clinical management strategy that may have influenced patient outcomes.

This abstract and the presentation materials are available to members only; a login is required.

Join Here